- Home
- HSCS vs LCFY Comparison
HSCS vs LCFY Comparison
Compare HSCS & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- LCFY
- Stock Information
- Founded
- HSCS 2007
- LCFY 2009
- Country
- HSCS United States
- LCFY Australia
- Employees
- HSCS N/A
- LCFY N/A
- Industry
- HSCS Medical Specialities
- LCFY
- Sector
- HSCS Health Care
- LCFY
- Exchange
- HSCS Nasdaq
- LCFY Nasdaq
- Market Cap
- HSCS 3.7M
- LCFY 3.7M
- IPO Year
- HSCS 2022
- LCFY 2022
- Fundamental
- Price
- HSCS $3.57
- LCFY $5.42
- Analyst Decision
- HSCS Strong Buy
- LCFY
- Analyst Count
- HSCS 2
- LCFY 0
- Target Price
- HSCS $13.00
- LCFY N/A
- AVG Volume (30 Days)
- HSCS 50.6K
- LCFY 4.9M
- Earning Date
- HSCS 07-28-2025
- LCFY 07-07-2025
- Dividend Yield
- HSCS N/A
- LCFY N/A
- EPS Growth
- HSCS N/A
- LCFY N/A
- EPS
- HSCS N/A
- LCFY N/A
- Revenue
- HSCS N/A
- LCFY $2,668,385.00
- Revenue This Year
- HSCS N/A
- LCFY N/A
- Revenue Next Year
- HSCS N/A
- LCFY N/A
- P/E Ratio
- HSCS N/A
- LCFY N/A
- Revenue Growth
- HSCS 261.17
- LCFY N/A
- 52 Week Low
- HSCS $2.36
- LCFY $2.28
- 52 Week High
- HSCS $5.30
- LCFY $13.98
- Technical
- Relative Strength Index (RSI)
- HSCS 46.34
- LCFY 55.67
- Support Level
- HSCS $3.63
- LCFY $5.16
- Resistance Level
- HSCS $3.92
- LCFY $13.98
- Average True Range (ATR)
- HSCS 0.31
- LCFY 1.03
- MACD
- HSCS -0.02
- LCFY 0.35
- Stochastic Oscillator
- HSCS 8.75
- LCFY 23.53
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.